Radiation therapy and chemotherapy combination.
D000284:Administration, Oral; D000963:Antimetabolites / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D006931:Hyperbaric Oxygenation; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011743:Pyrimidines / Q000008:administration & dosage
D000963:Antimetabolites; D011743:Pyrimidines; D008727:Methotrexate